» Articles » PMID: 15220702

Delayed Presentation and Late Testing for HIV: Demographic and Behavioral Risk Factors in a Multicenter Study in Italy

Abstract

Ensuring timely access to care for persons with HIV is an important public health goal. To identify factors associated with delayed presentation to medical care after testing HIV-positive or with late HIV testing, we studied 968 patients at their first HIV care visit, enrolled in a multicenter study in Italy from 1997-2000. Patients completed a questionnaire on HIV-testing history, sexual behavior, and drug use behavior. Delayed presenters were patients with >6 months between their first HIV-positive test and presentation for HIV care; late testers were patients with CD4 count < 200 /mm or clinically defined AIDS at their first HIV-positive test. Among the study patients, 255 (26.3%) were delayed presenters, and 280 (28.9%) were late testers. In multinomial logistic regression analysis, injection drug use significantly increased (odds ratio [OR]= 5.04) the probability of delayed presentation but reduced (OR = 0.55) the chance of late testing. A previous HIV-negative test was associated with a reduced risk of both delayed presentation (OR = 0.39) and late testing (OR = 0.36). Unemployment was positively associated with delayed presentation and increasing age with late testing, whereas HIV counseling at the time of first positive HIV test strongly (OR = 0.42) reduced the odds of delayed presentation. Interventions aimed at promoting timely access to care of HIV-infected persons should consider differentiated programs for delayed presentation and late testing.

Citing Articles

Real-world effectiveness of WHO recommended first-line antiretroviral therapies: a cohort study from a middle-income country.

Meireles G, Nobre A, Cardoso S, Velasque L, Veloso V, Grinsztejn B AIDS Care. 2023; 35(12):1891-1903.

PMID: 37001113 PMC: 10935654. DOI: 10.1080/09540121.2023.2190954.


An exploratory study to characterize the HIV testing-to-care continuum to improve outcomes for Black and Latinx residents of South Los Angeles.

McAndrew B, Gil N, Lee D, Teklehaimanot S, Schrode K, Bailey S PLoS One. 2022; 17(8):e0268374.

PMID: 36040966 PMC: 9426881. DOI: 10.1371/journal.pone.0268374.


Characteristics and clinical outcomes of patients presenting with advanced HIV disease in the "treat all" era: a retrospective cohort study from rural Rwanda.

Musengimana G, Umugisha J, Habinshuti P, Anderson T, Mukesharurema G, Remera E BMC Infect Dis. 2022; 22(1):706.

PMID: 36008786 PMC: 9404671. DOI: 10.1186/s12879-022-07692-w.


Effects of Human Immunodeficiency Virus Infection and Former Cocaine Dependence on Neuroanatomical Measures and Neurocognitive Performance.

Wakim K, Freedman E, Tivarus M, Christensen Z, Molholm S, Foxe J Neuroscience. 2022; 502:77-90.

PMID: 35963584 PMC: 9588737. DOI: 10.1016/j.neuroscience.2022.08.008.


The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis.

Farhadian N, Karami Matin B, Farnia V, Zamanian M, Najafi F, Farhadian M Subst Abuse Treat Prev Policy. 2022; 17(1):11.

PMID: 35144631 PMC: 8832672. DOI: 10.1186/s13011-022-00439-5.